iSpecimen Inc.
ISPC · XNASCIK 1558569fmd_06KG4K3E9J9PVK2EBF521NEPE2Services · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 8 | 11 | 10 | 10 | 9 | 2 |
| Cost of revenue | 4 | 5 | 5 | 5 | 5 | 2 |
| Gross profit | 5 | 6 | 6 | 5 | 4 | 0 |
| Research and development | 0 | 1 | 1 | 2 | 1 | – |
| Selling, general and administrative | 4 | 8 | 10 | 10 | 11 | 6 |
| Operating income | (2) | (6) | (10) | (11) | (13) | (9) |
| Interest expense | 2 | 2 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | – | – | 0 | 0 |
| Other non-operating income (expense) | (2) | (3) | (0) | 0 | 0 | (2) |
| Income tax expense | 0 | 0 | 0 | – | – | – |
| Net income | (5) | (9) | (10) | (11) | (12) | (10) |